2 A recent report from the Centers for Disease ... About NARCAN ® Nasal Spray NARCAN ® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product ...

Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

KLOXXADO is a prescription 8 mg naloxone nasal spray designed for the emergency treatment ... Currently, EBS is trading at $9.66 up by 2.66%. The views and opinions expressed herein are the ...

Emergent distributes NARCAN® Nasal Spray 4 mg, which is the first FDA-approved over-the-counter naloxone product for the emergency treatment of opioid overdose. Under the terms of the ...

Hikma Pharmaceuticals (HKMPF) announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (EBS) for the sale of Kloxxado naloxone HCl nasal spray 8 mg in the U.S ...

Emergent distributes NARCAN Nasal Spray 4 mg, which is the first FDA-approved over-the-counter naloxone product for the emergency treatment of opioid overdose. Under the terms of the six-year ...

GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S ...

Padagis OTC Naloxone HCl Nasal Spray, 4 mg, is an original prescription-strength solution designed to rapidly reverse the effects of a life-threatening opioid emergency. The spray is easy to use ...

Alongside over-the-counter NARCAN ® Nasal Spray 4 mg, prescription KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose ...

"Meeting the needs of our patients and customers by now offering two nasal naloxone products at different strengths - NARCAN ® Nasal Spray 4 mg and KLOXXADO ® Nasal Spray 8 mg - allows Emergent to do ...